ONTOLOGY REPORT - ANNOTATIONS
| Term: | thioacetamide |
|
| Accession: | CHEBI:32497
|
browse the term
|
| Definition: | A thiocarboxamide consiting of acetamide having the oxygen replaced by sulfur. |
| Synonyms: | exact_synonym: | ethanethioamide |
| | related_synonym: | Acetothioamide; C2H5NS; CC(N)=S; InChI=1S/C2H5NS/c1-2(3)4/h1H3,(H2,3,4); InChIKey=YUKQRDCYNOVPGJ-UHFFFAOYSA-N; TAA; Thiacetamide; Thioacetimidic acid; Thioactamide; acetic acid thioamide; methylthioamide |
| | xref_casrn: | 62-55-5 |
| | xref: | Beilstein:506006 "Beilstein Registry Number"; ChEMBL:156928 "ChEMBL COMPOUND"; ChemIDplus:62-55-5 "CAS Registry Number"; CiteXplore:20138653 "PubMed citation"; CiteXplore:20534638 "PubMed citation"; CiteXplore:20931291 "PubMed citation"; CiteXplore:21182490 "PubMed citation"; CiteXplore:21455425 "PubMed citation"; CiteXplore:21489598 "PubMed citation"; CiteXplore:21647311 "PubMed citation"; CiteXplore:21699073 "PubMed citation"; CiteXplore:21733084 "PubMed citation"; CiteXplore:21733883 "PubMed citation"; CiteXplore:21749370 "PubMed citation" |
| | xref_mesh: | MESH:D013853 |
| | xref: | NIST Chemistry WebBook:62-55-5 "CAS Registry Number"; Reaxys:506006 "Reaxys Registry Number" |
|
|
thioacetamide
|
| G |
A2m |
alpha-2-macroglobulin |
|
increases expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects expression |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases expression |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
affects expression |
EXP |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Abhd14b |
abhydrolase domain containing 14b |
|
affects expression |
EXP |
8 |
111,592,329 |
111,596,366 |
RGD:6480464 |
CTD |
| G |
Abhd17a |
abhydrolase domain containing 17A |
|
affects expression |
EXP |
7 |
10,635,489 |
10,641,920 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
affects expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
affects expression |
EXP |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
|
decreases expression |
ISO |
1 |
41,922,020 |
41,940,074 |
RGD:6480464 |
CTD |
| G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
|
increases expression |
ISO |
15 |
32,719,863 |
32,764,748 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
affects expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
affects expression |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot12 |
acyl-CoA thioesterase 12 |
|
affects expression |
EXP |
2 |
21,984,849 |
22,035,224 |
RGD:6480464 |
CTD |
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
affects expression |
EXP |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
increases expression |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
affects expression |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Add1 |
adducin 1 (alpha) |
|
affects expression |
EXP |
14 |
81,750,430 |
81,808,919 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
affects expression |
EXP |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases expression |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
decreases response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adtrp |
androgen-dependent TFPI-regulating protein |
|
affects expression |
EXP |
17 |
28,815,650 |
28,879,571 |
RGD:6480464 |
CTD |
| G |
Afm |
afamin |
|
affects expression |
EXP |
14 |
19,049,664 |
19,082,977 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
affects expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
affects expression |
EXP |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akr7a2 |
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
|
affects expression |
EXP |
5 |
158,097,679 |
158,106,217 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
decreases expression |
ISO |
1 |
245,685,979 |
245,718,198 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects expression |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Alkbh7 |
alkB, alkylation repair homolog 7 (E. coli) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
decreases expression |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alpi |
alkaline phosphatase, intestinal |
|
decreases expression |
EXP |
9 |
85,892,887 |
85,896,353 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases expression |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
increases expression |
EXP |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
decreases expression |
ISO |
15 |
27,083,089 |
27,083,526 |
RGD:6480464 |
CTD |
| G |
Ap2m1 |
adaptor-related protein complex 2, mu 1 subunit |
|
affects expression |
EXP |
11 |
82,585,474 |
82,591,832 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
affects expression |
EXP |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
affects expression |
EXP |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
affects expression |
EXP |
10 |
97,725,088 |
97,739,213 |
RGD:6480464 |
CTD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
increases expression |
EXP |
10 |
97,725,088 |
97,739,213 |
RGD:6480464 |
CTD |
| G |
Apool |
apolipoprotein O-like |
|
affects expression |
EXP |
X |
100,911,059 |
100,979,133 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects expression |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
increases expression |
ISO |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
affects expression |
EXP |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Asgr2 |
asialoglycoprotein receptor 2 |
|
affects expression |
EXP |
10 |
56,942,683 |
56,955,742 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
affects expression |
EXP |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atp5e |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
decreases expression |
ISO |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp5s |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) |
|
affects expression |
EXP |
6 |
91,771,989 |
91,799,619 |
RGD:6480464 |
CTD |
| G |
Atp6ap2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
|
affects expression |
EXP |
X |
22,264,078 |
22,291,988 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
affects expression |
EXP |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1f |
ATPase, H transporting, lysosomal V1 subunit F |
|
affects expression |
EXP |
4 |
56,347,184 |
56,350,085 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
EXP |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
increases expression |
EXP |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
decreases expression |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Baat |
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
affects expression |
EXP |
5 |
66,245,786 |
66,254,757 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
increases expression |
EXP |
9 |
70,120,151 |
70,198,591 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl6b |
B-cell CLL/lymphoma 6, member B |
|
affects expression |
EXP |
10 |
57,063,162 |
57,068,306 |
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
affects expression |
EXP |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects expression |
EXP |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Btf3 |
basic transcription factor 3 |
|
affects expression |
EXP |
2 |
28,900,451 |
28,907,561 |
RGD:6480464 |
CTD |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
affects expression |
EXP |
10 |
57,881,783 |
57,886,434 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
affects expression |
EXP |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
|
affects expression |
EXP |
11 |
37,873,369 |
37,935,054 |
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
affects expression |
EXP |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
C7 |
complement component 7 |
|
affects expression |
EXP |
2 |
54,147,136 |
54,250,803 |
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
affects expression |
EXP |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
affects expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cadps2 |
Ca++-dependent secretion activator 2 |
|
affects expression |
EXP |
4 |
49,658,535 |
50,206,014 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
decreases expression |
ISO |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Caprin1 |
cell cycle associated protein 1 |
|
affects expression |
EXP |
3 |
89,062,097 |
89,093,093 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
affects expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
affects expression |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
EXP |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
EXP |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
decreases expression |
EXP |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Cd276 |
Cd276 molecule |
|
increases expression |
EXP |
8 |
62,331,017 |
62,361,346 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
increases expression |
EXP |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd79b |
Cd79b molecule, immunoglobulin-associated beta |
|
increases expression |
EXP |
10 |
95,703,129 |
95,706,275 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
EXP |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
increases expression |
EXP |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
affects localization |
EXP |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
EXP |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc7 |
cell division cycle 7 |
|
increases expression |
EXP |
14 |
3,421,621 |
3,441,738 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
increases expression |
EXP |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
increases expression |
EXP |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
increases expression |
EXP |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
increases expression |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects localization |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
EXP |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects localization |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
EXP |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
affects expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
increases expression |
EXP |
6 |
25,686,603 |
25,693,840 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
increases expression |
EXP |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenpi |
centromere protein I |
|
increases expression |
EXP |
X |
121,786,667 |
121,837,546 |
RGD:6480464 |
CTD |
| G |
Cenpk |
centromere protein K |
|
increases expression |
EXP |
2 |
35,159,157 |
35,182,167 |
RGD:6480464 |
CTD |
| G |
Cenpn |
centromere protein N |
|
increases expression |
EXP |
19 |
47,029,240 |
47,051,557 |
RGD:6480464 |
CTD |
| G |
Cenpq |
centromere protein Q |
|
increases expression |
EXP |
9 |
15,758,645 |
15,768,747 |
RGD:6480464 |
CTD |
| G |
Cenpt |
centromere protein T |
|
increases expression |
EXP |
19 |
35,680,014 |
35,686,455 |
RGD:6480464 |
CTD |
| G |
Cep290 |
centrosomal protein 290 |
|
increases expression |
EXP |
7 |
38,138,545 |
38,228,716 |
RGD:6480464 |
CTD |
| G |
Cep55 |
centrosomal protein 55 |
|
increases expression |
EXP |
1 |
242,382,809 |
242,398,281 |
RGD:6480464 |
CTD |
| G |
Cep70 |
centrosomal protein 70 |
|
increases expression |
EXP |
8 |
104,118,970 |
104,162,318 |
RGD:6480464 |
CTD |
| G |
Cep78 |
centrosomal protein 78 |
|
increases expression |
EXP |
1 |
219,319,422 |
219,348,011 |
RGD:6480464 |
CTD |
| G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
|
affects expression |
EXP |
2 |
201,801,921 |
201,843,259 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
affects expression |
EXP |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Cfi |
complement factor I |
|
affects expression |
EXP |
2 |
227,281,621 |
227,325,109 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
increases expression |
EXP |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
increases phosphorylation |
EXP |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chp |
calcium binding protein p22 |
|
affects expression |
EXP |
3 |
106,066,389 |
106,101,635 |
RGD:6480464 |
CTD |
| G |
Cisd1 |
CDGSH iron sulfur domain 1 |
|
affects expression |
EXP |
20 |
17,985,985 |
17,999,366 |
RGD:6480464 |
CTD |
| G |
Clcn4 |
chloride channel, voltage-sensitive 4 |
|
affects expression |
EXP |
X |
44,355,648 |
44,419,524 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
increases expression |
EXP |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Clpp |
ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Clptm1l |
CLPTM1-like |
|
affects expression |
EXP |
1 |
30,474,672 |
30,490,655 |
RGD:6480464 |
CTD |
| G |
Cmbl |
carboxymethylenebutenolidase homolog (Pseudomonas) |
|
affects expression |
EXP |
2 |
83,659,292 |
83,681,042 |
RGD:6480464 |
CTD |
| G |
Cmpk1 |
cytidine monophosphate (UMP-CMP) kinase 1 |
|
affects expression |
EXP |
5 |
135,320,845 |
135,348,973 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
increases expression |
EXP |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
multiple interactions |
EXP |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a3 |
collagen, type IV, alpha 3 |
|
decreases expression |
EXP |
9 |
81,910,656 |
82,036,998 |
RGD:6480464 |
CTD |
| G |
Copg1 |
coatomer protein complex, subunit gamma 1 |
|
affects expression |
EXP |
4 |
122,109,613 |
122,134,049 |
RGD:6480464 |
CTD |
| G |
Cops4 |
COP9 signalosome subunit 4 |
|
affects expression |
EXP |
14 |
10,329,870 |
10,360,081 |
RGD:6480464 |
CTD |
| G |
Coq3 |
coenzyme Q3 homolog, methyltransferase (S. cerevisiae) |
|
affects expression |
EXP |
5 |
36,640,718 |
36,656,981 |
RGD:6480464 |
CTD |
| G |
Cox4i1 |
cytochrome c oxidase subunit IV isoform 1 |
|
affects expression |
EXP |
19 |
51,023,960 |
51,030,200 |
RGD:6480464 |
CTD |
| G |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpq |
carboxypeptidase Q |
|
affects expression |
EXP |
7 |
68,430,069 |
68,900,500 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
affects expression |
EXP |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
decreases expression |
EXP |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Csnk2b |
casein kinase 2, beta polypeptide |
|
affects expression |
EXP |
20 |
3,764,565 |
3,768,985 |
RGD:6480464 |
CTD |
| G |
Csrp1 |
cysteine and glycine-rich protein 1 |
|
affects expression |
EXP |
13 |
48,750,202 |
48,775,815 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
affects expression |
EXP |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
EXP |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
EXP |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
EXP |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyc1 |
cytochrome c-1 |
|
decreases expression |
ISO |
7 |
114,394,178 |
114,396,563 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
multiple interactions |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
multiple interactions |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
multiple interactions |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
multiple interactions |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases expression |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
affects expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
decreases expression |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
affects expression |
EXP |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects expression |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases response to substance |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
affects expression |
EXP |
1 |
82,191,741 |
82,204,629 |
RGD:6480464 |
CTD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
affects expression |
EXP |
5 |
116,702,370 |
116,729,722 |
RGD:6480464 |
CTD |
| G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
|
affects expression |
EXP |
1 |
82,229,581 |
82,233,249 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
decreases expression |
EXP |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
affects expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
affects expression |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
|
affects expression |
EXP |
7 |
13,609,104 |
13,636,290 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
decreases expression |
ISO |
15 |
32,285,592 |
32,305,885 |
RGD:6480464 |
CTD |
| G |
Dak |
dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
affects expression |
EXP |
1 |
213,081,825 |
213,095,034 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
|
affects expression |
EXP |
15 |
33,691,576 |
33,701,328 |
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
decreases expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddx39a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
increases expression |
EXP |
19 |
26,109,094 |
26,117,042 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
affects expression |
EXP |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Dexi |
dexamethasone-induced transcript |
|
affects expression |
EXP |
10 |
5,072,036 |
5,084,723 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
affects expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
affects expression |
EXP |
5 |
127,637,438 |
127,662,621 |
RGD:6480464 |
CTD |
| G |
Dhrs4 |
dehydrogenase/reductase (SDR family) member 4 |
|
affects expression |
EXP |
15 |
33,609,570 |
33,621,142 |
RGD:6480464 |
CTD |
| G |
Dhrs7b |
dehydrogenase/reductase (SDR family) member 7B |
|
affects expression |
EXP |
10 |
46,971,430 |
47,003,953 |
RGD:6480464 |
CTD |
| G |
Dhx16 |
DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
|
affects expression |
EXP |
20 |
3,009,770 |
3,022,969 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
affects expression |
EXP |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
affects expression |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
affects expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
EXP |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
increases expression |
EXP |
17 |
41,079,346 |
41,145,568 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
increases expression |
EXP |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
Ears2 |
glutamyl-tRNA synthetase 2, mitochondrial |
|
affects expression |
EXP |
1 |
180,861,635 |
180,889,473 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
affects expression |
EXP |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
affects expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Eci2 |
enoyl-CoA delta isomerase 2 |
|
affects expression |
EXP |
17 |
36,198,752 |
36,215,199 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
affects expression |
EXP |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression |
EXP |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
increases expression |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Eif1l1 |
eukaryotic translation initiation factor 1-like 1 |
|
increases expression |
ISO |
5 |
21,736,137 |
21,736,478 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
affects expression |
EXP |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
affects expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4h |
eukaryotic translation initiation factor 4H |
|
affects expression |
EXP |
12 |
23,148,332 |
23,164,980 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
affects expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
affects expression |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
increases expression |
EXP |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
affects expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
affects expression |
EXP |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases activity |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
affects expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Erp29 |
endoplasmic reticulum protein 29 |
|
affects expression |
EXP |
12 |
36,225,110 |
36,231,363 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D |
|
affects expression |
EXP |
15 |
55,556,681 |
55,576,172 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
affects expression |
EXP |
1 |
93,820,124 |
93,834,288 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
affects expression |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
affects expression |
EXP |
1 |
212,512,691 |
212,542,622 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases expression |
EXP |
4 |
149,424,558 |
149,500,006 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbn1 |
fibrillin 1 |
|
multiple interactions |
EXP |
3 |
112,608,480 |
112,804,118 |
RGD:6480464 |
CTD |
| G |
Fbn1 |
fibrillin 1 |
|
increases expression |
EXP |
3 |
112,608,480 |
112,804,118 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
affects expression |
EXP |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
affects expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
affects expression |
EXP |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdx1l |
ferredoxin 1-like |
|
affects expression |
EXP |
8 |
20,091,424 |
20,096,340 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
multiple interactions |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
increases expression |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
affects expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
multiple interactions |
EXP |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
decreases expression |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate N-methyltransferase |
|
affects expression |
EXP |
7 |
10,959,990 |
10,962,720 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
decreases expression |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gbe1 |
glucan (1,4-alpha-), branching enzyme 1 |
|
affects expression |
EXP |
11 |
8,720,408 |
8,975,471 |
RGD:6480464 |
CTD |
| G |
Gc |
group specific component |
|
increases expression |
EXP |
14 |
20,166,243 |
20,197,060 |
RGD:6480464 |
CTD |
| G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
|
affects expression |
EXP |
3 |
105,683,288 |
105,687,349 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Ggh |
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
affects expression |
EXP |
5 |
34,670,883 |
34,693,791 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
affects response to substance |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
affects expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
decreases expression |
ISO |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
|
decreases expression |
ISO |
16 |
6,429,357 |
6,444,262 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
affects expression |
EXP |
17 |
47,145,567 |
47,188,345 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases expression |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
affects expression |
EXP |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
affects expression |
EXP |
7 |
114,277,208 |
114,280,339 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
decreases expression |
EXP |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
affects expression |
EXP |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
EXP |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
EXP |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
decreases expression |
EXP |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
EXP |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
decreases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gtf2h5 |
general transcription factor IIH, polypeptide 5 |
|
affects expression |
EXP |
1 |
40,858,997 |
40,865,571 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
increases expression |
EXP |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
affects expression |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Gzma |
granzyme A |
|
affects expression |
EXP |
2 |
44,488,295 |
44,500,128 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
affects expression |
EXP |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
decreases expression |
EXP |
2 |
228,698,545 |
228,751,691 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
affects expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
affects expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
affects expression |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
affects expression |
EXP |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
EXP |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hgd |
homogentisate 1, 2-dioxygenase |
|
affects expression |
EXP |
11 |
64,876,269 |
64,928,243 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases response to substance |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hk3 |
hexokinase 3 (white cell) |
|
decreases expression |
EXP |
17 |
15,651,953 |
15,669,109 |
RGD:6480464 |
CTD |
| G |
Hmgn1 |
high mobility group nucleosome binding domain 1 |
|
affects expression |
EXP |
11 |
36,429,800 |
36,435,719 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
affects expression |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hps5 |
Hermansky-Pudlak syndrome 5 |
|
affects expression |
EXP |
1 |
97,312,474 |
97,351,792 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
increases expression |
ISO |
14 |
10,144,322 |
10,185,115 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
increases expression |
EXP |
14 |
10,144,322 |
10,185,115 |
RGD:6480464 |
CTD |
| G |
Hrsp12 |
heat-responsive protein 12 |
|
affects expression |
EXP |
7 |
69,930,464 |
69,944,267 |
RGD:6480464 |
CTD |
| G |
Hsbp1 |
heat shock factor binding protein 1 |
|
multiple interactions |
EXP |
19 |
49,589,574 |
49,594,599 |
RGD:6480464 |
CTD |
| G |
Hsbp1 |
heat shock factor binding protein 1 |
|
increases expression |
EXP |
19 |
49,589,574 |
49,594,599 |
RGD:6480464 |
CTD |
| G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression |
EXP |
18 |
45,157,435 |
45,251,606 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
affects expression |
EXP |
5 |
77,680,173 |
77,716,789 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
affects expression |
EXP |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Ica1 |
islet cell autoantigen 1 |
|
increases expression |
EXP |
4 |
33,680,878 |
33,830,443 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
affects expression |
EXP |
10 |
14,127,416 |
14,130,662 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
decreases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
affects expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
affects expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
decreases expression |
EXP |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
decreases expression |
EXP |
11 |
76,092,252 |
76,222,576 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases activity |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impa1 |
Inositol (myo)-1(or 4)-monophosphatase 1 |
|
affects expression |
EXP |
2 |
93,415,958 |
93,438,247 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
affects expression |
EXP |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
affects expression |
EXP |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
increases expression |
ISO |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
affects expression |
EXP |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
affects expression |
EXP |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
increases expression |
EXP |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Kdelr2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
increases expression |
EXP |
5 |
137,473,698 |
137,498,974 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
affects expression |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
affects expression |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
|
affects expression |
EXP |
1 |
182,242,293 |
182,298,243 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
decreases expression |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases response to substance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases response to substance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
affects expression |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
LOC100360920 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
EXP |
12 |
11,498,420 |
11,513,595 |
RGD:6480464 |
CTD |
| G |
LOC100361295 |
methylmalonyl-Coenzyme A mutase |
|
affects expression |
EXP |
9 |
15,768,911 |
15,797,489 |
RGD:6480464 |
CTD |
| G |
LOC100363268 |
rCG31129-like |
|
affects expression |
EXP |
2 |
189,674,857 |
189,675,177 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
affects expression |
EXP |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lrp3 |
low density lipoprotein receptor-related protein 3 |
|
affects expression |
EXP |
1 |
87,711,390 |
87,725,636 |
RGD:6480464 |
CTD |
| G |
Lsmd1 |
LSM domain containing 1 |
|
affects expression |
EXP |
10 |
56,190,119 |
56,191,724 |
RGD:6480464 |
CTD |
| G |
Ltb4r |
leukotriene B4 receptor |
|
decreases expression |
EXP |
15 |
33,928,726 |
33,929,781 |
RGD:6480464 |
CTD |
| G |
Lyz2 |
lysozyme 2 |
|
increases expression |
EXP |
7 |
56,607,708 |
56,613,004 |
RGD:6480464 |
CTD |
| G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
|
affects expression |
EXP |
19 |
24,711,378 |
24,730,659 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
affects expression |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
EXP |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases activity |
EXP |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map9 |
microtubule-associated protein 9 |
|
increases expression |
EXP |
2 |
174,056,831 |
174,089,399 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
affects expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Masp2 |
mannan-binding lectin serine peptidase 2 |
|
affects expression |
EXP |
5 |
165,682,509 |
165,696,426 |
RGD:6480464 |
CTD |
| G |
Mat1a |
methionine adenosyltransferase I, alpha |
|
decreases expression |
EXP |
16 |
17,548,582 |
17,563,989 |
RGD:6480464 |
CTD |
| G |
Mat2a |
methionine adenosyltransferase II, alpha |
|
increases expression |
EXP |
4 |
105,739,943 |
105,745,472 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
affects expression |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
EXP |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
EXP |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp8 |
matrix metallopeptidase 8 |
|
multiple interactions |
ISO |
8 |
4,402,124 |
4,410,976 |
RGD:6480464 |
CTD |
| G |
Mmp8 |
matrix metallopeptidase 8 |
|
increases expression |
ISO |
8 |
4,402,124 |
4,410,976 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mphosph6 |
M phase phosphoprotein 6 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mphosph6-ps1 |
M phase phosphoprotein 6, pseudogene |
|
increases expression |
EXP |
6 |
103,512,896 |
103,513,378 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mro |
maestro |
|
affects expression |
EXP |
18 |
70,648,892 |
70,660,961 |
RGD:6480464 |
CTD |
| G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
|
affects expression |
EXP |
9 |
10,016,260 |
10,020,033 |
RGD:6480464 |
CTD |
| G |
mrpl9 |
mitochondrial ribosomal protein L9 |
|
affects expression |
EXP |
2 |
189,417,391 |
189,422,111 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects response to substance |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects response to substance |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mut |
methylmalonyl CoA mutase |
|
affects expression |
EXP |
9 |
16,065,495 |
16,093,956 |
RGD:6480464 |
CTD |
| G |
Myadm |
myeloid-associated differentiation marker |
|
affects expression |
EXP |
1 |
64,177,547 |
64,185,893 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mycbp2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
15 |
87,124,558 |
87,364,839 |
RGD:6480464 |
CTD |
| G |
Myo1d |
myosin ID |
|
affects expression |
EXP |
10 |
68,720,729 |
68,997,721 |
RGD:6480464 |
CTD |
| G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
affects expression |
EXP |
7 |
50,506,870 |
50,530,177 |
RGD:6480464 |
CTD |
| G |
Nat8 |
N-acetyltransferase 8 |
|
affects expression |
EXP |
4 |
120,001,277 |
120,002,055 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
affects expression |
EXP |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndufs5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5 |
|
affects expression |
EXP |
5 |
143,017,421 |
143,023,425 |
RGD:6480464 |
CTD |
| G |
Ndufv3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3 |
|
affects expression |
EXP |
20 |
9,951,109 |
9,960,265 |
RGD:6480464 |
CTD |
| G |
Neu2 |
sialidase 2 |
|
affects expression |
EXP |
9 |
86,553,196 |
86,556,412 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
|
affects expression |
EXP |
5 |
58,366,449 |
58,424,124 |
RGD:6480464 |
CTD |
| G |
Nit1 |
nitrilase 1 |
|
affects expression |
EXP |
13 |
87,242,619 |
87,246,055 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
affects expression |
EXP |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nme3 |
NME/NM23 nucleoside diphosphate kinase 3 |
|
decreases expression |
EXP |
10 |
14,145,488 |
14,146,444 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
affects expression |
EXP |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects expression |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
increases expression |
EXP |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Nt5e |
5' nucleotidase, ecto |
|
increases response to substance |
ISO |
8 |
93,591,630 |
93,635,481 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
EXP |
13 |
85,286,634 |
85,315,366 |
RGD:6480464 |
CTD |
| G |
Nxf1 |
nuclear RNA export factor 1 |
|
decreases expression |
EXP |
1 |
211,428,605 |
211,441,798 |
RGD:6480464 |
CTD |
| G |
Oaf |
OAF homolog (Drosophila) |
|
affects expression |
EXP |
8 |
46,224,861 |
46,242,832 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
ISO |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
affects expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
increases expression |
EXP |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
affects expression |
EXP |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
Olr59 |
olfactory receptor 59 |
|
affects expression |
EXP |
1 |
160,607,895 |
160,613,826 |
RGD:6480464 |
CTD |
| G |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
|
affects expression |
EXP |
2 |
228,112,093 |
228,127,992 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
affects expression |
EXP |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
|
affects expression |
EXP |
5 |
142,599,706 |
142,615,003 |
RGD:6480464 |
CTD |
| G |
Paics |
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
|
affects expression |
EXP |
14 |
33,492,707 |
33,509,389 |
RGD:6480464 |
CTD |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
increases expression |
EXP |
1 |
155,057,622 |
155,174,714 |
RGD:6480464 |
CTD |
| G |
Pak3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
|
increases expression |
EXP |
X |
34,734,814 |
34,842,093 |
RGD:6480464 |
CTD |
| G |
Pak6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
|
increases expression |
EXP |
3 |
105,141,150 |
105,191,676 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
affects expression |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pccb |
propionyl CoA carboxylase, beta polypeptide |
|
affects expression |
EXP |
8 |
105,946,482 |
105,996,472 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
affects expression |
EXP |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pctp |
phosphatidylcholine transfer protein |
|
affects expression |
EXP |
10 |
78,400,328 |
78,420,774 |
RGD:6480464 |
CTD |
| G |
Pdcl3 |
phosducin-like 3 |
|
affects expression |
EXP |
9 |
38,004,222 |
38,012,693 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
increases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
increases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
affects expression |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pex14 |
peroxisomal biogenesis factor 14 |
|
increases expression |
EXP |
5 |
166,038,317 |
166,174,652 |
RGD:6480464 |
CTD |
| G |
Pex19 |
peroxisomal biogenesis factor 19 |
|
affects expression |
EXP |
13 |
88,122,462 |
88,139,003 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgrmc1 |
progesterone receptor membrane component 1 |
|
affects expression |
EXP |
X |
8,265,543 |
8,273,667 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
EXP |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
EXP |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
affects expression |
EXP |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
|
affects expression |
EXP |
11 |
34,610,876 |
34,617,001 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
affects expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Plbd1 |
phospholipase B domain containing 1 |
|
affects expression |
EXP |
4 |
173,611,465 |
173,667,759 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
affects expression |
EXP |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
increases expression |
EXP |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
increases expression |
EXP |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Pls3 |
plastin 3 |
|
affects expression |
EXP |
X |
29,868,937 |
29,965,118 |
RGD:6480464 |
CTD |
| G |
Polr1b |
polymerase (RNA) I polypeptide B |
|
decreases expression |
EXP |
3 |
116,706,483 |
116,730,946 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
affects expression |
EXP |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
increases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Ppdpf |
pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) |
|
affects expression |
EXP |
3 |
170,329,529 |
170,330,471 |
RGD:6480464 |
CTD |
| G |
Pqlc1 |
PQ loop repeat containing 1 |
|
affects expression |
EXP |
18 |
77,151,194 |
77,187,603 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
increases expression |
EXP |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
affects expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
affects expression |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prelid1 |
PRELI domain containing 1 |
|
decreases expression |
ISO |
17 |
15,350,084 |
15,353,124 |
RGD:6480464 |
CTD |
| G |
Proc |
protein C |
|
affects expression |
EXP |
18 |
24,563,368 |
24,573,715 |
RGD:6480464 |
CTD |
| G |
Prpsap1 |
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
|
affects expression |
EXP |
10 |
106,582,381 |
106,604,072 |
RGD:6480464 |
CTD |
| G |
Psma6 |
proteasome (prosome, macropain) subunit, alpha type 6 |
|
affects expression |
EXP |
6 |
75,649,844 |
75,667,404 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
affects expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
affects expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
affects expression |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc3 |
proteasome (prosome, macropain) 26S subunit, ATPase 3 |
|
affects expression |
EXP |
3 |
75,413,567 |
75,418,948 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
affects expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
affects expression |
EXP |
9 |
84,807,822 |
84,882,942 |
RGD:6480464 |
CTD |
| G |
Psmd4 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression |
EXP |
2 |
189,933,161 |
189,942,421 |
RGD:6480464 |
CTD |
| G |
Psme3 |
proteasome (prosome, macropain) activator subunit 3 |
|
decreases expression |
ISO |
10 |
90,343,493 |
90,351,335 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
affects expression |
EXP |
4 |
161,041,242 |
161,045,145 |
RGD:6480464 |
CTD |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
affects expression |
EXP |
5 |
138,671,725 |
138,739,002 |
RGD:6480464 |
CTD |
| G |
Pttg1ip |
pituitary tumor-transforming 1 interacting protein |
|
affects expression |
EXP |
20 |
11,414,678 |
11,431,939 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
affects expression |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Pzp |
pregnancy-zone protein |
|
affects expression |
EXP |
4 |
165,505,104 |
165,579,027 |
RGD:6480464 |
CTD |
| G |
Rab19 |
RAB19, member RAS oncogene family |
|
increases expression |
EXP |
4 |
66,889,446 |
66,899,175 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
increases expression |
EXP |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
increases expression |
EXP |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
decreases expression |
EXP |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
RGD1307752 |
similar to RIKEN cDNA 1110008F13 |
|
affects expression |
EXP |
3 |
147,266,788 |
147,276,798 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
affects expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnase6 |
ribonuclease, RNase A family, 6 |
|
increases expression |
EXP |
15 |
27,117,646 |
27,118,107 |
RGD:6480464 |
CTD |
| G |
Rnf103 |
ring finger protein 103 |
|
affects expression |
EXP |
4 |
104,762,184 |
104,778,157 |
RGD:6480464 |
CTD |
| G |
Rnps1 |
ribonucleic acid binding protein S1 |
|
affects expression |
EXP |
10 |
13,670,753 |
13,681,591 |
RGD:6480464 |
CTD |
| G |
Rpl11 |
ribosomal protein L11 |
|
affects expression |
EXP |
5 |
154,826,973 |
154,830,183 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
affects expression |
EXP |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl15 |
ribosomal protein L15 |
|
affects expression |
EXP |
15 |
9,082,190 |
9,085,473 |
RGD:6480464 |
CTD |
| G |
Rpl17 |
ribosomal protein L17 |
|
affects expression |
EXP |
18 |
71,863,062 |
71,866,168 |
RGD:6480464 |
CTD |
| G |
Rpl17l1 |
ribosomal protein L17-like 1 |
|
affects expression |
EXP |
1 |
64,205,419 |
64,205,973 |
RGD:6480464 |
CTD |
| G |
Rpl23 |
ribosomal protein L23 |
|
affects expression |
EXP |
10 |
86,527,589 |
86,531,549 |
RGD:6480464 |
CTD |
| G |
Rpl3 |
ribosomal protein L3 |
|
affects expression |
EXP |
7 |
118,314,537 |
118,319,911 |
RGD:6480464 |
CTD |
| G |
Rpl32 |
ribosomal protein L32 |
|
affects expression |
EXP |
4 |
151,941,599 |
151,945,012 |
RGD:6480464 |
CTD |
| G |
Rpl4 |
ribosomal protein L4 |
|
affects expression |
EXP |
8 |
68,366,802 |
68,371,925 |
RGD:6480464 |
CTD |
| G |
Rpn2 |
ribophorin II |
|
affects expression |
EXP |
3 |
147,976,544 |
148,023,743 |
RGD:6480464 |
CTD |
| G |
Rps14 |
ribosomal protein S14 |
|
affects expression |
EXP |
18 |
56,727,647 |
56,732,431 |
RGD:6480464 |
CTD |
| G |
Rps18 |
ribosomal protein S18 |
|
affects expression |
EXP |
20 |
5,083,626 |
5,087,304 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
affects expression |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps20 |
ribosomal protein S20 |
|
affects expression |
EXP |
5 |
17,119,797 |
17,120,959 |
RGD:6480464 |
CTD |
| G |
Rps3a |
ribosomal protein S3a |
|
affects expression |
EXP |
2 |
178,092,351 |
178,096,720 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
affects expression |
EXP |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
decreases expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rps8 |
ribosomal protein S8 |
|
affects expression |
EXP |
5 |
137,466,705 |
137,469,275 |
RGD:6480464 |
CTD |
| G |
Rras2 |
related RAS viral (r-ras) oncogene homolog 2 |
|
affects expression |
EXP |
1 |
172,026,262 |
172,097,710 |
RGD:6480464 |
CTD |
| G |
Rrs1 |
RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) |
|
increases expression |
ISO |
5 |
9,304,448 |
9,306,081 |
RGD:6480464 |
CTD |
| G |
RT1-DOa |
RT1 class II, locus DOa |
|
increases expression |
EXP |
20 |
4,890,410 |
4,894,048 |
RGD:6480464 |
CTD |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
affects expression |
EXP |
20 |
2,815,943 |
2,820,644 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
affects expression |
EXP |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
|
affects expression |
EXP |
5 |
2,516,220 |
2,547,152 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scfd1 |
sec1 family domain containing 1 |
|
decreases expression |
ISO |
6 |
71,453,366 |
71,532,347 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
affects expression |
EXP |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
decreases expression |
EXP |
1 |
29,739,359 |
29,764,329 |
RGD:6480464 |
CTD |
| G |
Sdhc |
succinate dehydrogenase complex, subunit C, integral membrane protein |
|
affects expression |
EXP |
13 |
87,014,569 |
87,035,239 |
RGD:6480464 |
CTD |
| G |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
|
affects expression |
EXP |
8 |
53,955,067 |
53,964,547 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
multiple interactions |
EXP |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
decreases expression |
EXP |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sec13 |
SEC13 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
149,637,058 |
149,650,449 |
RGD:6480464 |
CTD |
| G |
Sec23a |
Sec23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
6 |
79,660,575 |
79,706,898 |
RGD:6480464 |
CTD |
| G |
Serinc3 |
serine incorporator 3 |
|
affects expression |
EXP |
3 |
154,539,792 |
154,559,239 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
affects expression |
EXP |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpina10 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
|
affects expression |
EXP |
6 |
127,887,684 |
127,896,122 |
RGD:6480464 |
CTD |
| G |
Serpina4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression |
EXP |
6 |
128,133,692 |
128,142,768 |
RGD:6480464 |
CTD |
| G |
Serpina6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
|
decreases expression |
ISO |
6 |
127,911,618 |
127,921,851 |
RGD:6480464 |
CTD |
| G |
Serpinf2 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
affects expression |
EXP |
10 |
62,748,116 |
62,756,200 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
affects expression |
EXP |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
|
affects expression |
EXP |
7 |
67,494,470 |
67,499,540 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
affects expression |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
affects expression |
EXP |
18 |
28,238,953 |
28,250,889 |
RGD:6480464 |
CTD |
| G |
Slc25a13 |
solute carrier family 25 (aspartate/glutamate carrier), member 13 |
|
affects expression |
EXP |
4 |
30,822,456 |
31,006,241 |
RGD:6480464 |
CTD |
| G |
Slc25a3 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 |
|
affects expression |
EXP |
7 |
28,054,665 |
28,061,801 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
affects expression |
EXP |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
affects expression |
EXP |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
affects expression |
EXP |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
affects expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
increases expression |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smox |
spermine oxidase |
|
increases expression |
ISO |
3 |
119,240,376 |
119,254,370 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
decreases expression |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases activity |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
EXP |
3 |
51,361,185 |
51,374,357 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sppl2a |
signal peptide peptidase-like 2A |
|
affects expression |
EXP |
3 |
114,428,234 |
114,469,506 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
decreases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srm |
spermidine synthase |
|
affects expression |
EXP |
5 |
165,672,516 |
165,675,673 |
RGD:6480464 |
CTD |
| G |
Srprb |
signal recognition particle receptor, B subunit |
|
affects expression |
EXP |
8 |
108,196,684 |
108,210,631 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
decreases expression |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
Ssx2ip |
synovial sarcoma, X breakpoint 2 interacting protein |
|
affects expression |
EXP |
2 |
244,604,360 |
244,637,562 |
RGD:6480464 |
CTD |
| G |
St3gal6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
|
affects expression |
EXP |
11 |
42,893,712 |
42,937,792 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
affects expression |
EXP |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
|
increases expression |
EXP |
4 |
180,722,382 |
180,852,639 |
RGD:6480464 |
CTD |
| G |
Strbp |
spermatid perinuclear RNA binding protein |
|
decreases expression |
ISO |
3 |
17,338,337 |
17,411,975 |
RGD:6480464 |
CTD |
| G |
Suclg1 |
succinate-CoA ligase, alpha subunit |
|
affects expression |
EXP |
4 |
106,572,140 |
106,601,495 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
decreases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
decreases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
decreases expression |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Surf4 |
surfeit 4 |
|
affects expression |
EXP |
3 |
5,817,200 |
5,830,060 |
RGD:6480464 |
CTD |
| G |
Synj2bp |
synaptojanin 2 binding protein |
|
affects expression |
EXP |
6 |
105,352,102 |
105,389,779 |
RGD:6480464 |
CTD |
| G |
Tes |
testis derived transcript |
|
increases expression |
EXP |
4 |
42,680,722 |
42,719,246 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
affects response to substance |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
EXP |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
EXP |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
EXP |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
EXP |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
affects expression |
EXP |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
decreases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
decreases expression |
EXP |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
decreases expression |
EXP |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Thnsl2 |
threonine synthase-like 2 (S. cerevisiae) |
|
affects expression |
EXP |
4 |
104,329,517 |
104,348,465 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
decreases expression |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Timm21 |
translocase of inner mitochondrial membrane 21 homolog (yeast) |
|
affects expression |
EXP |
18 |
81,524,258 |
81,528,720 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
increases expression |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tm9sf1 |
transmembrane 9 superfamily member 1 |
|
decreases expression |
ISO |
15 |
33,771,498 |
33,778,965 |
RGD:6480464 |
CTD |
| G |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
|
affects expression |
EXP |
9 |
73,614,825 |
73,632,005 |
RGD:6480464 |
CTD |
| G |
Tmco1 |
transmembrane and coiled-coil domains 1 |
|
affects expression |
EXP |
13 |
82,971,926 |
82,995,262 |
RGD:6480464 |
CTD |
| G |
Tmed2 |
transmembrane emp24 domain trafficking protein 2 |
|
affects expression |
EXP |
12 |
33,165,291 |
33,174,326 |
RGD:6480464 |
CTD |
| G |
Tmed7 |
transmembrane emp24 protein transport domain containing 7 |
|
affects expression |
EXP |
18 |
40,800,887 |
40,808,002 |
RGD:6480464 |
CTD |
| G |
Tmem123 |
transmembrane protein 123 |
|
affects expression |
EXP |
8 |
4,604,130 |
4,632,932 |
RGD:6480464 |
CTD |
| G |
Tmem184c |
transmembrane protein 184C |
|
increases expression |
EXP |
19 |
32,158,361 |
32,174,009 |
RGD:6480464 |
CTD |
| G |
Tmem97 |
transmembrane protein 97 |
|
decreases expression |
ISO |
10 |
64,652,641 |
64,661,724 |
RGD:6480464 |
CTD |
| G |
Tmem97 |
transmembrane protein 97 |
|
affects expression |
EXP |
10 |
64,652,641 |
64,661,724 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases activity |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpx2 |
TPX2, microtubule-associated, homolog (Xenopus laevis) |
|
increases expression |
EXP |
3 |
143,194,067 |
143,236,185 |
RGD:6480464 |
CTD |
| G |
Trhde |
thyrotropin-releasing hormone degrading enzyme |
|
decreases activity |
EXP |
7 |
53,591,770 |
54,021,219 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
affects expression |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
multiple interactions |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases response to substance |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnl1 |
thioredoxin-like 1 |
|
affects expression |
EXP |
18 |
59,823,127 |
59,849,853 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases activity |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
affects expression |
EXP |
16 |
19,425,401 |
19,427,557 |
RGD:6480464 |
CTD |
| G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
|
affects expression |
EXP |
7 |
32,719,959 |
32,750,002 |
RGD:6480464 |
CTD |
| G |
Ufd1l |
ubiquitin fusion degradation 1 like (yeast) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
affects expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Uhrf1bp1l |
UHRF1 binding protein 1-like |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects expression |
EXP |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
|
decreases expression |
ISO |
1 |
179,459,817 |
179,490,381 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
affects expression |
EXP |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Wdr26 |
WD repeat domain 26 |
|
affects expression |
EXP |
13 |
96,944,266 |
96,984,348 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
decreases phosphorylation |
EXP |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
increases expression |
EXP |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
affects expression |
EXP |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Zdhhc23 |
zinc finger, DHHC-type containing 23 |
|
affects expression |
EXP |
11 |
58,286,189 |
58,296,769 |
RGD:6480464 |
CTD |
Term paths to the root
|